Principles of medical therapy for endometriosis pain

References

• Andrews M. C., Andrews W. C., Strauss A. F. Effects of progestin-induced pseudopregnancy on endometriosis: clinical and microscopic studies. American Journal of Obstetrics and Gynecology 1959; 78: 776–785
   PubMed Web of Science ®Google Scholar
• Barbieri R. L., Evans S., Kistner R. W. Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up. Fertility and Sterility 1982; 37: 737–746
   PubMed Web of Science ®Google Scholar
• Bergquist C. Effects of nafarelin versus danazol on lipids and calcium metabolism. American Journal of Obstetrics and Gynecology 1990; 162: 589–591
   Google Scholar
• Cedars M. I., Lu J. K. H., Meldrum D. R., Judd H. L. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate. Obstetrics and Gynecology 1990; 75: 641–645
   PubMed Web of Science ®Google Scholar
• Coutinho E. M. Treatment of endometriosis with gestrinone (R-2323), a synthetic antiestrogen, antiprogesterone. American Journal of Obstetrics and Gynecology 1982; 144: 895–898
   Google Scholar
• Czernobilsky B., Morris W. J. A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes. Obstetrics and Gynecology 1979; 53: 318–323
   PubMed Web of Science ®Google Scholar
• Fraser I. S., Shearman R. P., Jansen R. P. S., Sutherland P. D. A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol. Australian and New Zealand Journal of Obstetrics and Gynaecology 1991; 31: 158–163
   PubMed Web of Science ®Google Scholar
• Gunning J. E., Moyer D. The effect of medroxyprogesterone acetate on endometriosis in the human female. Fertility and Sterility 1967; 18: 759–774
   Google Scholar
• Henzl M. R., Corson S. L., Moghissi K., Buttram V. C., Bergquist C., Jacobson J. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. New England Journal of Medicine 1989; 318: 485–489
   Google Scholar
• Henzl M. R., Kwei L. Efficacy and safety of nafarelin in the treatment of endometriosis. American Journal of Obstetrics and Gynecology 1990; 162: 570–574
   PubMed Web of Science ®Google Scholar
• Hirst J. C. Conservative treatment and therapeutic test for endometriosis by androgens. American Journal of Obstetrics and Gynecology 1947; 53: 483–487
   PubMed Web of Science ®Google Scholar
• Jacobson J. B. Effects of nafarelin on bone density. American Journal of Obstetrics and Gynecology 1990; 162: 591–592
   PubMedGoogle Scholar
• Jansen R. P. S., Russell P. Nonpigmented endometriosis. Clinical, laparoscopic and pathologic definition. American Journal of Obstetrics and Gynecology 1986; 155: 1154–1159
   PubMed Web of Science ®Google Scholar
• Jänne O., Kauppila A., Kokko E., Lantto T., Rönnberg L., Vihko R. Estrogen and progestin receptors in endometriosis lesions: comparison with endometrial tissue. American Journal of Obstetrics and Gynecology 1981; 141: 562–566
   PubMed Web of Science ®Google Scholar
• Johnston W. I. H. Dydrogesterone and endometriosis. British Journal of Obstetrics and Gynaecology 1976; 83: 77–80
   PubMedGoogle Scholar
• Kistner R. W. The treatment of endometriosis by inducing pseudopregnancy with ovarian hormones. A report of fifty-eight cases. Fertility and Sterility 1959; 10: 539–556
   Web of Science ®Google Scholar
• Koninckx P. R., Heyns W., Verhoeven G., Van Baelen H., Lissens W. D., De Moor P., Brosens J. A. Biochemical characterization of peritoneal fluid in women during the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 1980; 51: 1239–1244
   Google Scholar
• Luciano A. A., Turksoy R. N., Carleo I. Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. Obstetrics and Gynecology 1988; 72: 323–327
   PubMed Web of Science ®Google Scholar
• Mercaitis P., Peaper R. E., Schwartz P. A. Effect of danazol on vocal pitch: a case study. Obstetrics and Gynecology 1985; 65: 131–135
   PubMed Web of Science ®Google Scholar
• Noble A. D., Letchworth A. T. Medical treatment of endometriosis: a comparative trial. Postgraduate Medical Journal 1979; 55(supplement 5)37–39
   Google Scholar
• Ranney B. The prevention, inhibition, palliation, and treatment of endometriosis. American Journal of Obstetrics and Gynecology 1975; 123: 778–785
   Google Scholar
• Reid B. A., Gangar K. F., Beard R. W. Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapy. British Journal of Obstetrics and Gynaecology 1992; 99: 344–345
   Google Scholar
• Roland M., Leisten D., Kane R. Endometriosis therapy with medroxyprogesterone acetate. Journal of Reproductive Medicine 1976; 11: 249–252
   Google Scholar
• Shaw R. W., Fraser H. M., Boyle H. Intra-nasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis. British Medical Journal 1983; 287: 1667–1669
   Google Scholar
• Shaw R. W. The role of GnRH analogues in the treatment of endometriosis. British Journal of Obstetrics and Gynaecology 1992; 99(supplement 7)9–12
   Google Scholar
• Telimaa S., Penttilä I., Puolakka J., Rönnberg L., Kauppila A. Circulating lipid and lipoprotein concentrations during danazol and high-dose medroxyprogesterone acetate therapy of endometriosis. Fertility and Sterility 1989; 52: 31–35
   Google Scholar
• Telimaa S., Apter D., Reinila M., Rönnberg L., Kauppila A. Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate. European Journal of Obstetrics, Gynaecology and Reproductive Biology 1990; 36: 97–105
   Google Scholar
• Thomas E. J. Combining medical and surgical treatment for endometriosis: the best of both worlds. British Journal of Obstetrics and Gynaecology 1992; 99(supplement 7)5–8
   Google Scholar
• Wardle P. G., Whitehead M. I., Mills R. P. Non-reversible and wide ranging voice changes after treatment with danazol. British Medical Journal 1983; 287: 946
   PubMed Web of Science ®Google Scholar